A Phase 1 Study to Evaluate the Effect of Itraconazole on thePharmacokinetics of GS-5718 and to Evaluate the Effect of GS-5718 on the Pharmacokinetics of Rosuvastatin in Healthy Subjects
Latest Information Update: 11 Mar 2022
At a glance
- Drugs Edecesertib (Primary) ; Itraconazole (Primary) ; Rosuvastatin (Primary)
- Indications Cutaneous lupus erythematosus; Inflammatory bowel diseases; Rheumatoid arthritis; Systemic lupus erythematosus
- Focus Pharmacokinetics
- Sponsors Gilead Sciences
- 24 Jun 2021 New trial record